Louisiana Mother Files Risperdal Lawsuit On Behalf Of Son Claiming Gynecomastia Side Effect

April 04, 2016 – – LegalHerald.com reports on a Risperdal lawsuit filed by a woman in Louisiana on behalf of her 17-year-old son in the District Court for the Eastern District of Louisiana against drug manufacturer Johnson & Johnson. The son was diagnosed with gynecomastia (male breast growth) after taking Risperdal, which his mother claims was caused by the drug.

Gynecomastia is a swelling of the breast tissue in men which is caused by a hormone imbalance. According to a study published in 2009 in Journal of Child and Adolescent Psychopharmacology, Risperdal was found to significantly increase the levels of prolactin, a hormone normally released in the body to stimulate the production of breast milk and breast growth. This breast tissue growth in men is benign, yet can be destructive to their emotional, social, and mental health, especially among adolescents. Surgery is usually required to correct severe cases.

Risperdal is an atypical antipsychotic drug which was originally approved by the FDA in 2002 for the treatment of schizophrenia in adults and in 2003 for the short-term treatment of acute mania and for mixed episodes associated with Bipolar 1 Disorder. Several side effects have been linked to the drug in addition to gynecomastia such as high blood sugar and diabetes, medically serious weight gain, tardive dyskinesia (involuntary muscle movements), and heart attacks.

The plaintiff, in this case, will be joining over 1,000 others who have filed lawsuits against Risperdal manufacturer Johnson & Johnson which allege that the company failed to provide consumers with adequate warnings regarding the potential side effect of gynecomastia for those taking the drug. While some lawsuits have already been settled, the remaining suits have been consolidated by the Philadelphia Court of Common Pleas to form a Multidistrict Litigation.

The attorneys of Banville Law understand the anguish that potential side effects of Risperdal may cause patients. They are devoted to keeping the public informed of the latest Risperdal lawsuit information and sponsor the resource website LegalHerald.com to assist in accomplishing this. As lawsuits continue to be filed, the attorneys of Banville Law wish to assist any patients who have taken Risperdal and believe that they were negatively affected by the drug. These patients may be entitled to compensation. Banville Law is currently offering complimentary consultations to those affected who wish to take legal action.

For more information on Risperdal lawsuits, or to ask questions, please contact the lawyers at Banville Law by calling 888-997-3792.

###

Contact Banville Law:

Laurence Banville, Esq.
888-997-3792
info@banvillelaw.com
165 West End Avenue, #1H
New York, NY 10023
United States (US)

ReleaseID: 60009063